Войти в систему Зарегистрироваться бесплатно

Alimera Sciences Прибыль на акцию Q/Q

Что обозначает Прибыль на акцию Q/Q в Alimera Sciences?

Прибыль на акцию Q/Q Alimera Sciences Inc. является -143.69%

Какое определение для Прибыль на акцию Q/Q?



Ежеквартальный темп роста прибыли на акцию, по сравнению с предыдущим кварталом, представляет собой увеличение прибыли на акцию компании за последние 4 квартала по сравнению с показателями за предыдущие 4 квартала.

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Прибыль на акцию Q/Q компаний в Health Care сектор на NASDAQ по сравнению с Alimera Sciences

Что делает Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Компании с прибыль на акцию q/q похож на Alimera Sciences